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Appendices  
 
Sample search strategy (Medline) 
1. Very low calorie diet.ab,hw,kw,ot,sh,ti. 
2. Very low energy diet.ab,hw,kw,ot,sh,ti. 
3. Vlcd.ab,hw,kw,ot,sh,ti. 
4. Vled.ab,hw,kw,ot,sh,ti. 
5. Very-low-calorie.ab,hw,kw,ot,sh,ti. 
6. Very-low-energy.ab,hw,kw,ot,sh,ti. 
7. Very low calorie.ab,hw,kw,ot,sh,ti. 
8. Very low energy.ab,hw,kw,ot,sh,ti. 
9. Very-low-calorie diet.ab,hw,kw,ot,sh,ti. 
10. Very-low-energy diet.ab,hw,kw,ot,sh,ti. 
11. Cambridge diet.ab,hw,kw,ot,sh,ti. 
12. Lighterlife.ab,hw,kw,ot,sh,ti. 
13. Diet.ab,hw,kw,ot,sh,ti. 
14. Diets.ab,hw,kw,ot,sh,ti. 
15. "Obes*".ab,hw,kw,ot,sh,ti. 
16. Overweight.ab,hw,kw,ot,sh,ti. 
17. Weight loss.ab,hw,kw,ot,sh,ti. 
18. Dieting.ab,hw,kw,ot,sh,ti. 
19. "Lighter life".ab,hw,kw,ot,sh,ti. 
20. weight change.ab,hw,kw,ot,sh,ti. 
21. 13 or 14 or 15 or 16 or 17 or 18 or 20  
22. nutrilett.ab,hw,kw,ot,sh,ti. 
23. modifast.ab. or modifast.ot. or modifast.sh. or modifast.ti. 
24. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 19 or 22 or 23  
25. 21 and 24  
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Supplementary tables and figures  
Table S1: Excluded full papers  
Paper Grounds for exclusion 
Lantz 2003 (1) Intermittent VLED 
Ryttig 1995 (2) Intermittent VLED 
Wing 1984 (3) Intermittent VLED 
Viegener 1990 (4) Intermittent VLED 
Torgerson 1999 (5) VLED in comparator arm 
Wadden  1985 (6) VLED in comparator arm 
Snel 2011 (7) VLED in comparator arm 
Snel 2012 (8) VLED in comparator arm 
Pavlou 1989 (9) VLED in comparator arm 
Rossner 1998 (10) VLED in comparator arm 
Dixon 2012 (11) Surgical comparator 
Andersen 1987 (12) Surgical comparator 
Gripeteg 2010 (13) Weight maintenance 
Lecheminant 2005 (14) Weight maintenance 
Wikstrand 2010 (15) Non-randomized study 
Murray 2010 (16) Non-randomized study 
Christensen 2010 (17) Non-randomized study 
Richelsen  2007 (18) Non-randomized study 
Mathus-Vliegen 2005  (19) Non-randomized study 
Kajaste 2004 (20) Non-randomized study 
Zahouani 2003 (21) Non-randomized study 
Kaukua 2003 (22) Non-randomized study 
Melin 2003 (23) Non-randomized study 
Paisey 1998 (24) Non-randomized study 
Andersen 1992 (25) Non-randomized study 
Apfelbaum 1999 (26) Non-randomized study 
Paisey 2002 (27) Non-randomized study 
Wadden 1997 (28) Non-randomized study 
Capstick 1997 (29) Non-randomized study 
Agras 1996 (30) Non-randomized study 
Kamrath 1992 (31) Non-randomized study 
Sikand  1988 (32) Non-randomized study 
Finer 1989 (33) Non-randomized study 
Shovic 1993 (34) Non-randomized study 
Miura 1989 (35) Non-randomized study 
Anderson  2001 (36) Review article 
Tsai 2006 (37) Review article 
Kreitzman 1989 (38) Review article 
Lin 2009 (39) Follow-up less than 12 months 
Kaukua 2002 (40) Follow-up less than 12 months 
Arai  1992 (41) Follow-up less than 12 months 
Foster 1990 (42) Follow-up less than 12 months 
Foster 1992 (43) Follow-up less than 12 months 
Inoue 1989 (44) Follow-up less than 12 months 
Toubro 1997 (45) Authors unable to provide data requested 
Simonen 2000 (46) Authors unable to provide data requested 
Wadden 1989 (47) Authors unable to provide data requested 
Rolland trial protocol 2011 (48) Authors unable to provide data requested 
Bliddal 2011 (49) VLED contained more than 800kcal/day 
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Table S2: Summary of study characteristics 
Study  ID Location  Population  Intervention  Comparator Outcomes reported 
during study  
Follow Up 
and % 
completers 
Pekkarinen 
1997 (50) 
Finland  N=59, 
morbidly 
obese, 57.8% 
F  
Dietta Mini, liquid 
meal and vegetables 
for 6-8 weeks, 
500Kcal/day  
Low energy food from 
14 weeks 
Behavioural therapy 
for 16 weeks  
Behavioural therapy 
for 16 weeks 
Weight change, 5% 
weight loss, 10% 
weight loss, 20% 
weight loss, SCL-90 
GSI scores, dietary 
adherence, adverse 
effects 
4, 60 
months.  
 
Completers: 
44% 
comparator, 
50% 
intervention 
at 60 
months. 
 
Purcell 2014 
(51) 
Australia N=200, obese, 
74.5% F 
Optifast meal 
replacements, 450-
800kcal/day for 12 
weeks (replacing 
meals) then 
individualised diet for 
weight maintenance, 
if regain changed to 
400-500kcal/day 
deficit diet up to 144 
weeks. 
 
Behavioural therapy 
every 2 weeks (6 
sessions) and then 
every 12 weeks for 
144 weeks. 
400-500kcal/day 
deficit diet for 36 
weeks with 1 or 2 
meals replaced by 
Optifast a day. Then 
maintenance as 
intervention up to 
144 weeks. 
 
 
 
 
 
Behavioural therapy 
every 2 weeks (18 
sessions) and then 
every 12 weeks for 
144 weeks. 
Weight change, 
fasting gherlin and 
leptin levels, 
subjective appetite, 
change in physical 
activity levels, fat 
mass, fat free mass, 
hip circumference 
and waist 
circumference 
3-β-
hydroxybutyrate 
levels, adverse 
events 
12 weeks-
rapid group, 
36 weeks-
gradual 
group), 144 
weeks -both 
groups, 
(data from 
authors at 
48 and 108 
weeks). 
 
Completers: 
44% 
comparator, 
64% 
intervention 
at 48 weeks. 
 
Completers: 
28% 
comparator, 
52% 
intervention 
at 108 
weeks. 
Rolland 2009 
& 2010 (52, 
53) 
UK  N=72, obese, 
84% F 
600kcal/day deficit 
diet and lifestyle 
advice for 9 months 
initially and failed to 
lose >5% body weight 
Lighterlife, food 
replacements for 3-9 
months, 550Kcal/day  
Behavioural therapy 
with weekly group 
sessions  
Constant support via 
email and telephone 
600kcal/day deficit 
diet and lifestyle 
advice for 9 months 
initially and failed to 
lose >5% body weight 
Low calorie high 
protein (800-1500 
kcal/day, ≤40g 
carbohydrate/ day) 
Constant support via 
email and telephone 
Weight change, 
body composition, 
waist 
circumference, BP, 
lipids, electrolytes, 
eGFR, fasting 
glucose, fasting 
insulin, HbA1c, 
bilirubin, albumin 
3, 9 and 24 
months. 
 
Completers: 
26% 
comparator, 
29% 
intervention 
at 24 
months. 
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Rossner 1997 
(54) 
Norway  N=93, obese, 
68% F 
Nutrilett, food 
substitutes for 6 
weeks 
Booster for 2 weeks 
at 27 weeks  
1) 420Kcal/day 
2) 530Kcal/day  
HCD between VLED 
and after VLED up to 
52 weeks. 
 
Behavioural support 
sessions, from 26-52 
weeks 
LCD  (880kcal/day) for 
6 weeks 
 
Booster for 2 weeks 
at 27 weeks 
 
 
HCD between LCD 
and after LCD up to 
52 weeks. 
 
Behavioural support 
sessions, as per 
intervention arm 
 
Weight change, % 
body fat, waist 
circumference, hip 
circumference, 
WHR, sagittal 
diameter, ECG, BP*, 
lipids*, glucose*, 
adverse effects 
1,6 and 12 
months. 
 
Completers: 
55% 
comparator, 
70% 
intervention 
420kcal, 
59% 
intervention 
530kcal at 
12 months. 
Ryttig 1997 
(55)  
Sweden  N=81, obese, 
54.3% F  
Nutrilett, liquid, for 2 
months, 420Kcal/day  
1 week transition 
then balanced deficit 
diet to 1600kcal/ day 
for 26 months 
Behavioural therapy 
for 26 months 
(weekly for first 
month, then every 
fortnight for second 
month, monthly for 
months 3-9 and every 
7 weeks for months 
10-26) 
Balanced deficit diet 
with 1600kcal/day for 
26 months 
 
Behavioural therapy 
for 26 months as 
intervention 
Weight change, % 
body fat loss, wasit 
circumference, BP, 
HR, ECG, 
electrolytes, 
glucose, 
cholesterol, urine 
ketone body, 
adverse effects 
2, 8, 12 and 
24 months. 
 
Completers:  
78% 
comparator, 
74% 
intervention 
at 12 
months. 
 
Completers: 
59% 
comparator, 
48% 
intervention 
at 24 
months. 
Stenius 2000 
(56) 
Finland  N=38, obese, 
asthma, 
76.3% F  
Nutrilett, liquid for 8 
weeks, 420Kcal/day  
Transition period over 
8 weeks and then 
500-1000 kcal/ day 
deficit diet 
Behavioural therapy 
group weekly for 12 
weeks 
Behavioural therapy 
group weekly for 12 
weeks 
Weight change, PEF 
**, FVC, FEV1, QoL 
(SGRQ), asthma 
symptoms, acute 
episodes and use of 
oral steroids  
3 and 12 
months. 
 
Completers: 
100% 
comparator, 
100% 
intervention 
at 12 
months. 
Torgerson 
1997 & Lantz 
2003 (57, 58) 
Sweden  N=113, obese, 
65.5% F 
Modifast, liquid for 12 
weeks, 456-
608Kcal/day  
1200-1400kcal/ day 
(female) or 1400-
1800kcal/ day (male) 
diet for 21 months 
Behavioural therapy 
59 sessions over 4 
years 
1200-1400kcal/day 
(female) or 1400-
1800kcal/day (male) 
diet for 21 months 
Behavioural therapy 
56 sessions over 4 
years 
Weight change, 5%  
weight loss, 10% 
weight loss, adverse 
effects  
3, 6, 12, 18, 
24 and 48 
months. 
 
Completers: 
91% 
comparator, 
88% 
intervention 
at 12 
months. 
 
Completers: 
47% 
comparator, 
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50% 
intervention 
at 48 
months. 
Tuomilehto 
2009 & 2010 
(59, 60) 
Finland  N=81, 
overweight, 
mild OSA, 
26.35% F  
Modifast, Natrifast or 
Naturdiet for 12 
weeks, 600-
800Kcal/day  
Followed by fat 
restriction diet (no 
more than 30% total 
energy) 
Behavioural support 
14 sessions over 12 
months (6 during 
VLED phase) 
Brief intervention on 
diet and exercise 
given at baseline, 3 
and 12 months. 
Weight change, 
waist 
circumference, HR, 
lipids, BP, fasting 
glucose, fasting 
insulin, oxygen 
saturation, AHI**, 
ESS, SOS, QoL, 
number of 
witnessed apnoea, 
adverse effects 
3, 12 and 24 
months. 
 
Completers: 
90% 
comparator, 
88% 
intervention 
at 12 
months. 
 
Completers: 
88% 
comparator, 
88% 
intervention 
at 24 
months. 
Wadden 1986 
& 1988 (61, 
62)  
USA  N=59, 
overweight 
(obese in 
1988), 84.7% 
F 
Preceded by 1000-
1200kcal/ day diet for 
4 wks 
PSMF for 8 weeks, 
400-500Kcal/day 
Followed by refeeding 
period for  4 weeks 
and 8 weeks 1000-
1200kcal/ day diet 
1) VLED only as 
above 
2) VLED  as above 
and behavioural 
therapy over 12 
months (11 
sessions) 
1000-1200kcal/day 
diet for 6 months and 
behavioural therapy 
over 12 months (11 
sessions) 
Weight change, BDI  6, 12 and 42 
months. 
 
Completers: 
89% 
comparator, 
83% 
intervention 
(VLED 
alone), 74% 
intervention 
(VLED+BT) 
at 12 
months. 
 
Completers: 
83% 
comparator,
72% 
intervention 
(VLED 
alone), 74% 
intervention 
(VLED+BT) 
at 42 
months. 
Wadden 1994 
(63) 
USA  N=49, obese, 
100% F 
Preceded by 
1200kcal/ day diet for 
1 week 
Optifast, liquid for 16 
wks, 420Kcal/day 
Transition period for 
5 weeks, followed by 
28 weeks 1200kcal/ 
day diet and then 26 
weeks of weight 
maintenance diet 
1200kcal/day diet  
 
Behavioural therapy 
as per intervention 
arm 
Weight change, 
body composition, 
% lost 5kg, % lost 
10kg, % lost 20kg, 
BDI, BES 
1, 2, 4, 6, 12 
and 18 
months. 
 
Completers: 
81% 
comparator, 
82% 
intervention 
at 12 
months. 
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Behavioural therapy 
weekly for 12 months 
and then biweekly for 
6 months 
Wing 1991 
(64) 
USA  N=36, obese, 
T2DM, 75.5% 
F  
Preceded by 1000-
1505 kcal/day diet for 
4 weeks 
Optifast, liquid or 
lean meat for 8 
weeks, 400Kcal/day  
Transition period for 
8 weeks and then 
maintenance diet 
(1000-1505kcal/day) 
until week 72 
Behavioural therapy, 
24 sessions 
1000-1505kcal/day 
diet for 20 weeks 
minimum  
 
Remain on calorie 
deficit until target 
weight reached and 
then maintenance 
programme 
 
Behavioural therapy 
as per intervention 
arm 
Weight change, 
HbA1c, lipids, 
fasting insulin, 
fasting glucose, 
insulin:glucose 
ratio, PAQ, EBI, 
adverse effects 
5 and 17 
months. 
 
Completers: 
84% 
comparator, 
100% 
intervention 
at 17 
months. 
Wing 1994-
1996 (65-67) 
USA  N=93, obese, 
T2DM , 65% F 
Optifast, liquid or 
lean meat for 12 
weeks, 400-
500Kcal/day, second 
12 week phase of 
VLED after 24 weeks 
1000-1200kcal/day 
diet  for 12 weeks 
between VLED phases  
and after second 
VLED phase 
Behavioural therapy 
weekly for 50 
sessions  
1000-1200kcal/day 
diet 
 
Behavioural therapy 
weekly for 50 
sessions 
Weight change, 
HbA1c, lipids, 
fasting glucose, 
fasting insulin, BP, 
BDI, adverse effects 
3, 12 and 24 
months. 
 
Completers: 
85% 
comparator, 
84% 
intervention 
at 12 
months. 
 
Completers: 
77% 
comparator, 
80% 
intervention 
at 24 
months. 
 
* At baseline and 6 months only 
** Primary outcome 
SGRQ – St George’s Respiratory Questionnaire, PEF – Peak Expiratory Flow, FVC – Forced Vital Capacity, 
FEV1 – Forced Expiratory Volume in 1 minute, BDI – Beck Depression Index, ESS – Epworth Sleepiness 
Scale, SOS – Snore Outcome Survey, AHI – Apnoea Hyponea Index, PAQ – Paffenberger Activity 
Questionnaire, EBI – Eating Behaviour Inventory, BES – Binge Eating Scale, WHR – Waist Hip Ratio 
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Table S3: Risk of bias assessment 
 
Study ID Sequence 
generation 
Allocation 
concealment 
Attrition Selective reporting 
Pekkarinen 1997 High High Low Low 
Purcell 2014 Low Low Low Low 
Ryttig 1997 Unclear Unclear Unclear Low 
Wadden 1994 Unclear Unclear Low Low 
Wing 1991 Unclear Unclear Low Low 
Wing 1994 Unclear Unclear Low Low 
Stenius 2000 Unclear Low Low Low 
Wadden 1986 and 
1988 
Unclear Low Low Low 
Tuomilheto 2009 
and 2010 
Low Low Low High 
Rolland 2009 and 
2010 
Unclear Unclear Low Low 
Torgerson 1997 and 
Lantz 2003 
Unclear Low Low Unclear 
Rossner 1997 Unclear Unclear Low Low 
Note that blinding is not reported as it is not possible to blind therapists or participants.  Incomplete 
outcome data are not assessed either because we have addressed this in recalculating the 
outcomes. 
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Figure S1: Forest plot weight change at 12 months, complete data 
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Figure S2: Forest plot BOCF weight change at 12 months, subgroups on participant group 
 
 
 
 
  
11 
 
Figure S3: Forest plot BOCF weight change at 12 months, subgroups on formulation of 
VLED 
 
 
 
 
  
12 
 
Figure S4: Forest plot BOCF weight change at 12 months, subgroups on single or multiple 
VLED phase 
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Figure S5: Forest plot BOCF weight change at 24 months 
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Figure S6: Forest plot BOCF weight change at 38-60 months 
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Figure S7: Forest plot fasting glucose at 12 months (BOCF) 
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Figure S8: Forest plot HbA1c at 12 months (BOCF) 
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Figure S9: Forest plot fasting insulin at 12 months (BOCF) 
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Figure S10: Forest plot HDL at 12 months (BOCF) 
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Figure S11: Forest plot LDL at 12 months (BOCF) 
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Figure S12: Forest plot systolic BP at 12 months (BOCF) 
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Figure S13: Forest plot diastolic BP at 12 months (BOCF) 
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Figure S14: Forest plot BDI at 12 months (BOCF) 
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